FRANKLIN LAKES, N.J.,
July 22, 2019 /PRNewswire/
-- The Board of Directors of BD (Becton, Dickinson and
Company) (NYSE: BDX) has declared a quarterly dividend of
$0.77 per common share, payable on
September 30, 2019 to holders of
record on September 9, 2019.
The indicated annual dividend rate is $3.08 per share. In addition, the Board of
Directors has declared a quarterly dividend of $15.3125 per share on the 6.125% mandatory
convertible preferred stock, Series A, payable on November 1, 2019 to holders of record on
October 15, 2019. This
represents $0.7656 per depositary
share (NYSE: BDXA).
About BD
BD is one of the largest global medical technology companies in
the world and is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. The company
supports the heroes on the frontlines of healthcare by developing
innovative technology, services and solutions that help advance
both clinical therapy for patients and clinical process for
healthcare providers. BD and its 65,000 employees have a passion
and commitment to help enhance the safety and efficiency of
clinicians' care delivery process, enable laboratory scientists to
accurately detect disease and advance researchers' capabilities to
develop the next generation of diagnostics and therapeutics. BD has
a presence in virtually every country and partners with
organizations around the world to address some of the most
challenging global health issues. By working in close collaboration
with customers, BD can help enhance outcomes, lower costs, increase
efficiencies, improve safety and expand access to healthcare. For
more information on BD, please visit bd.com.
Contact:
Kristen Cardillo, Corporate
Communications – 201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-board-declares-dividends-300888976.html
SOURCE BD (Becton, Dickinson and Company)